Jazz Pharmaceuticals (JAZZ) EPS (Weighted Average and Diluted) (2016 - 2025)
Historic EPS (Weighted Average and Diluted) for Jazz Pharmaceuticals (JAZZ) over the last 17 years, with Q3 2025 value amounting to $4.08.
- Jazz Pharmaceuticals' EPS (Weighted Average and Diluted) rose 1929.82% to $4.08 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.22, marking a year-over-year decrease of 11715.89%. This contributed to the annual value of $8.51 for FY2024, which is 3952.32% up from last year.
- Jazz Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to $4.08 in Q3 2025, which was up 1929.82% from -$11.74 recorded in Q2 2025.
- In the past 5 years, Jazz Pharmaceuticals' EPS (Weighted Average and Diluted) ranged from a high of $4.08 in Q3 2025 and a low of -$11.74 during Q2 2025
- Over the past 5 years, Jazz Pharmaceuticals' median EPS (Weighted Average and Diluted) value was $0.8 (recorded in 2022), while the average stood at -$0.11.
- As far as peak fluctuations go, Jazz Pharmaceuticals' EPS (Weighted Average and Diluted) tumbled by 61111.11% in 2022, and later skyrocketed by 336666.67% in 2023.
- Over the past 5 years, Jazz Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.54 in 2021, then tumbled by 611.11% to -$3.84 in 2022, then soared by 137.24% to $1.43 in 2023, then surged by 102.49% to $2.9 in 2024, then soared by 40.9% to $4.08 in 2025.
- Its last three reported values are $4.08 in Q3 2025, -$11.74 for Q2 2025, and $2.9 during Q4 2024.